These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19368830)

  • 21. Sporadic amyotrophic lateral sclerosis: a hypothesis of persistent (non-lytic) enteroviral infection.
    Ravits J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Jun; 6(2):77-87. PubMed ID: 16036430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligodendroglia Confer Neuroprotection to NSC-34 Motor Neuronal Cells Against the Toxic Insults of Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients.
    Ramya V; Sarkar N; Bhagat S; Pradhan RK; Varghese AM; Nalini A; Sathyaprabha TN; Raju TR; Vijayalakshmi K
    Mol Neurobiol; 2023 Sep; 60(9):4855-4871. PubMed ID: 37184766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adaptation to G93Asuperoxide dismutase 1 in a motor neuron cell line model of amyotrophic lateral sclerosis: the role of glutathione.
    Tartari S; D'Alessandro G; Babetto E; Rizzardini M; Conforti L; Cantoni L
    FEBS J; 2009 May; 276(10):2861-74. PubMed ID: 19459941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microglia in amyotrophic lateral sclerosis.
    Dewil M; Van Den Bosch L; Robberecht W
    Acta Neurol Belg; 2007 Sep; 107(3):63-70. PubMed ID: 18072333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.
    Shanmukha S; Narayanappa G; Nalini A; Alladi PA; Raju TR
    Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased mitochondrial oxidative damage in patients with sporadic amyotrophic lateral sclerosis.
    Murata T; Ohtsuka C; Terayama Y
    J Neurol Sci; 2008 Apr; 267(1-2):66-9. PubMed ID: 17961597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transglutaminase activity in serum and cerebrospinal fluid in sporadic amyotrophic lateral sclerosis: a possible use as an indicator of extent of the motor neuron loss.
    Fujita K; Honda M; Hayashi R; Ogawa K; Ando M; Yamauchi M; Nagata Y
    J Neurol Sci; 1998 Jun; 158(1):53-7. PubMed ID: 9667778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased mitochondrial oxidative damage and oxidative DNA damage contributes to the neurodegenerative process in sporadic amyotrophic lateral sclerosis.
    Murata T; Ohtsuka C; Terayama Y
    Free Radic Res; 2008 Mar; 42(3):221-5. PubMed ID: 18344116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kennedy's disease: a lower motor neuron model to identify upper motor neuron physiology in ALS.
    Eisen A
    Clin Neurophysiol; 2008 May; 119(5):971-2. PubMed ID: 18308629
    [No Abstract]   [Full Text] [Related]  

  • 30. Axon guidance proteins: novel therapeutic targets for ALS?
    Schmidt ER; Pasterkamp RJ; van den Berg LH
    Prog Neurobiol; 2009 Aug; 88(4):286-301. PubMed ID: 19523502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of VEGF and VEGFR2 Receptor in Reversal of ALS-CSF Induced Degeneration of NSC-34 Motor Neuron Cell Line.
    Vijayalakshmi K; Ostwal P; Sumitha R; Shruthi S; Varghese AM; Mishra P; Manohari SG; Sagar BC; Sathyaprabha TN; Nalini A; Raju TR; Alladi PA
    Mol Neurobiol; 2015; 51(3):995-1007. PubMed ID: 24880751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered glutamatergic mechanisms and selective motor neuron degeneration in amyotrophic lateral sclerosis: possible role of glycine.
    Plaitakis A
    Adv Neurol; 1991; 56():319-26. PubMed ID: 1677233
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis.
    Andrés-Benito P; Povedano M; Domínguez R; Marco C; Colomina MJ; López-Pérez Ó; Santana I; Baldeiras I; Martínez-Yelámos S; Zerr I; Llorens F; Fernández-Irigoyen J; Santamaría E; Ferrer I
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33213069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen receptor function in motor neuron survival and degeneration.
    Cary GA; La Spada AR
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):479-94, viii. PubMed ID: 18625411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of vesicle-associated membrane-protein-associated protein B cleavage products in peripheral blood leukocytes and cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.
    Deidda I; Galizzi G; Passantino R; Cascio C; Russo D; Colletti T; La Bella V; Guarneri P
    Eur J Neurol; 2014 Mar; 21(3):478-85. PubMed ID: 24372953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular changes in motor neuron cell culture produced by cytotoxic cerebrospinal fluid from patients with amyotrophic lateral sclerosis.
    Gomez-Pinedo U; Yáñez M; Matías-Guiu J; Galán L; Guerrero-Sola A; Benito-Martin MS; Vela A; Arranz-Tagarro JA; García AG
    Neurologia; 2014; 29(6):346-52. PubMed ID: 24144827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of group I metabotropic glutamate receptors in human motoneurons at low and high risk of degeneration in amyotrophic lateral sclerosis.
    Ma L; Ostrovsky H; Miles G; Lipski J; Funk GD; Nicholson LF
    Neuroscience; 2006 Nov; 143(1):95-104. PubMed ID: 16979830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal Fluid from Patients with Sporadic Amyotrophic Lateral Sclerosis Induces Degeneration of Motor Neurons Derived from Human Embryonic Stem Cells.
    Sumitha R; Manjunatha VM; Sabitha RK; Alladi PA; Nalini A; Rao LT; Chandrasekhar Sagar BK; Steinbusch HWM; Kramer BW; Sathyaprabha TN; Raju TR
    Mol Neurobiol; 2019 Feb; 56(2):1014-1034. PubMed ID: 29858777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ALS CSF: effect on cultured neurons.
    Swift TR; Gulati AK; Rivner MH
    Muscle Nerve; 1988 Mar; 11(3):278. PubMed ID: 3352663
    [No Abstract]   [Full Text] [Related]  

  • 40. Experimental regimen targeting the ependyma slows disease progression in four patients with amyotrophic lateral sclerosis.
    Payne AG
    Med Hypotheses; 2009 May; 72(5):548-50. PubMed ID: 19200662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.